{
    "2018-02-15": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Glancy Prongay & Murray LLP Continues Investigation on Behalf of Johnson & Johnson Investors (JNJ)",
                "features": {
                    "keywords": [
                        "investigation",
                        "Johnson & Johnson",
                        "investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock)",
                "features": {
                    "keywords": [
                        "healthcare stocks",
                        "marijuana stock",
                        "gold medals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "marijuana"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "A Snapshot Of Abbott Labs' Business",
                "features": {
                    "keywords": [
                        "Abbott Labs",
                        "business snapshot"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-25",
                "original_text": "The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Klein Law Firm",
                        "investigation",
                        "violations",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-22",
                "original_text": "6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock)",
                "features": {
                    "keywords": [
                        "healthcare stocks",
                        "marijuana stock",
                        "gold medals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "marijuana"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-03",
                "original_text": "J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment",
                "features": {
                    "keywords": [
                        "J&J",
                        "FDA nod",
                        "prostrate cancer treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "How Pfizer’s Peri-LOE Products Performed in 2017",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Peri-LOE products",
                        "performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-05",
                "original_text": "Today’s Research Reports on Trending Tickers: Johnson & Johnson and Merck & Company",
                "features": {
                    "keywords": [
                        "research reports",
                        "trending tickers",
                        "Johnson & Johnson",
                        "Merck & Company"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-10",
                "original_text": "See what the IHS Markit Score report has to say about Johnson & Johnson.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "report",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-20",
                "original_text": "Where Pfizer’s Xeljanz Is Positioned for 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xeljanz",
                        "positioned"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-05",
                "original_text": "How Analysts View Bristol-Myers Squibb after Its 4Q17 Earnings",
                "features": {
                    "keywords": [
                        "analysts view",
                        "Bristol-Myers Squibb",
                        "4Q17 earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "Why Defensive ETFs Fail in the Market Downturn?",
                "features": {
                    "keywords": [
                        "defensive ETFs",
                        "market downturn"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}